Refreshing results…
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
UploadTargeting TBK1 to overcome resistance to cancer immunotherapy
Download from www.nature.comSupporting the next generation of scientists to lead cancer immunology research
Download from aacrjournals.orgMissing publications? Search for publications with a matching author name.